222 related articles for article (PubMed ID: 34161212)
1. Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer.
Verdi J; Ketabchi N; Noorbakhsh N; Saleh M; Ebrahimi-Barough S; Seyhoun I; Kavianpour M
Curr Stem Cell Res Ther; 2022; 17(1):91-102. PubMed ID: 34161212
[TBL] [Abstract][Full Text] [Related]
2. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
3. Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics.
Xia Z; Qing B; Wang W; Gu L; Chen H; Yuan Y
Thorac Cancer; 2021 Dec; 12(23):3088-3100. PubMed ID: 34734680
[TBL] [Abstract][Full Text] [Related]
4. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
5. Exosomes: small vesicles with big roles in hepatocellular carcinoma.
Wu Z; Zeng Q; Cao K; Sun Y
Oncotarget; 2016 Sep; 7(37):60687-60697. PubMed ID: 27463001
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
7. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets.
Liang B; Hu X; Ding Y; Liu M
J Cell Physiol; 2021 Jun; 236(6):4138-4151. PubMed ID: 33275291
[TBL] [Abstract][Full Text] [Related]
9. Exosomes in Cancer: Circulating Immune-Related Biomarkers.
Głuszko A; Szczepański MJ; Ludwig N; Mirza SM; Olejarz W
Biomed Res Int; 2019; 2019():1628029. PubMed ID: 31915681
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers.
Zheng H; Su N; Yan G; Li M; Chu H; Zhang J; Li B; Zhao J; Wang J; Gao M; Zhang X
Anal Chim Acta; 2024 Jan; 1287():342109. PubMed ID: 38182386
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis.
Chen H; Chengalvala V; Hu H; Sun D
Acta Pharm Sin B; 2021 Aug; 11(8):2136-2149. PubMed ID: 34522581
[TBL] [Abstract][Full Text] [Related]
12. Exosomes and cancer: from molecular mechanisms to clinical applications.
Jafari A; Babajani A; Abdollahpour-Alitappeh M; Ahmadi N; Rezaei-Tavirani M
Med Oncol; 2021 Mar; 38(4):45. PubMed ID: 33743101
[TBL] [Abstract][Full Text] [Related]
13. Exosomes: New insights into cancer mechanisms.
Sahebi R; Langari H; Fathinezhad Z; Bahari Sani Z; Avan A; Ghayour Mobarhan M; Rezayi M
J Cell Biochem; 2020 Jan; 121(1):7-16. PubMed ID: 31701565
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
Whiteside TL
Biochem Soc Trans; 2013 Feb; 41(1):245-51. PubMed ID: 23356291
[TBL] [Abstract][Full Text] [Related]
15. The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer.
Alipoor SD; Mortaz E; Varahram M; Movassaghi M; Kraneveld AD; Garssen J; Adcock IM
Front Immunol; 2018; 9():819. PubMed ID: 29720982
[TBL] [Abstract][Full Text] [Related]
16. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes.
Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G
Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived exosomes: immune properties and clinical application in lung cancer.
Wu J; Li S; Zhang P
Cancer Drug Resist; 2022; 5(1):102-113. PubMed ID: 35582534
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
[TBL] [Abstract][Full Text] [Related]
20. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]